Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.970
+0.110 (2.85%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $213.52 million as of July 10, 2026. Its market cap has increased by 142.38% in one year.
Market Cap
213.52M
Enterprise Value
90.48M
1-Year Change
142.38%
Ranking
Category
Stock Price
$3.97
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $213.52M, a decrease of -60.52%. That is a compound annual growth rate of -17.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 213.52M | 87.21% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 226.06M |
| Precision BioSciences | 226.03M |
| Camp4 Therapeutics | 224.84M |
| Codexis | 220.88M |
| Minerva Neurosciences | 219.90M |
| NovaBridge Biosciences | 219.73M |
| Cellectis | 214.98M |
| Atrium Therapeutics | 213.14M |